• 1
    Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48: 6918.
  • 2
    Walker ID. Blood Collection and Sample Preparation: Pre-Analytical Variation. In: Laboratory Techniques in Thrombosis. A Manual. Second revised edition of the ECAT assay procedures. (Edited by: JespersenJ, BertineRM, HaverkateF). Dordrecht, Kluwar Academic Publishers, 1992: 2128.
  • 3
    Narayanan S. Preanalytical aspects of coagulation testing. Haemtologica 1995; 2: 16.
  • 4
    Lawrence JB. Preanalytical variables in the coagulation laboratory. Lab Med 2003; 34: 4957.
  • 5
    NCCLS. Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard-Fifth Edition. NCCLS Document 2003;H3-A5:Vol 23 No 32.
  • 6
    Bush V, Cohen R. The evolution of evacuated blood collection tubes. Lab Med 2003; 34: 30410.
  • 7
    Yawn BP, Loge C, Dale J. Prothrombin time: one tube or two. Am J Clin Pathol 1996; 105: 7947.
  • 8
    Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol 1997; 107: 6813.
  • 9
    Adcock DM, Kressin DC, Marlar RA. Are discard tubes necessary in coagulation studies? Lab Med 1997; 28: 5303.
  • 10
    Brigden ML, Graydon C, McLeod B, Lesperance M. Prothrombin time determination: the lack of need for a discard tube and 24-hour stability. Am J Clin Pathol 1997; 108: 4226.
  • 11
    NCCLS. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays; Approved Guideline-Fourth Edition. NCCLS Document 2003;H21-A4:Vol 23 No 35.
  • 12
    NCCLS. Procedures for the Handling and Processing of Blood Specimens; Approved Guideline-Second Edition. NCCLS Document 1999;H18-A2:Vol 19 No 21.
  • 13
    Woodhams B, Girardot O, Blanco M-J, Colesse G, Gourmelin Y. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 2001; 12: 22936.
  • 14
    Verbruggen B, Meijer P, Novákova I, Van Heerde W. Diagnosis of factor VIII deficiency. Haemophilia 2008; 14: 7682.
  • 15
    Pouplard C, Trossaert M, Le Querrec A, Delahousse B, Giraudeau B, Gruel Y. Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B. Haemophilia 2009; 15: 3658.
  • 16
    Langdell RD, Wagner RH, Brinkhous KM. Effect of anti-hemophilic factor on one-stage clotting tests: a presumptive test for haemophilia and a simple one-stage anti-haemophilic factor assay procedure. J Lab Clin Med 1953; 41: 63747.
  • 17
    White GC II. The partial thromboplastin time: defining an era in coagulation. J Thromb Haemost 2003; 1: 226770.
  • 18
    Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 2129.
  • 19
    Fernandes B, Giles A. An abnormal activated partial thromboplastin time clotting waveform is associated with high mortality and procoagulant state. Lab Haematol 2003; 9: 13842.
  • 20
    Zadro R. Discrepancies between aPTT results determined with different evaluation modes on automated coagulation analyzers. Int J Lab Hematol 2010; 32(1pt2): 339.
  • 21
    Kitchen S, Olson JD, Preston E. Quality in Laboratory Haemostasis and Thrombosis. UK: Wiley-Blackwell, 2009.
  • 22
    Bing Bai, Douglas J, Robert T. Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory. Blood Coagul Fibrinolysis 2008; 19: 56976.